Representation and reporting of diverse groups in randomised controlled trials of pharmacological agents in inflammatory bowel disease: a systematic review

Oct 2023 | Publications

Authors: Mythili Menon Pathiyil, Anuraag Jena, Arvind Kumar Venkataramana Raju, Tina Aswani-Omprakash, Vishal Sharma, Shaji Sebastian

Journal: Lancet Gastroenterology and Hepatology

DOI Link

Highlighting the need for inclusion of historically underrepresented communities in randomized controlled trials that evaluate the efficacy of IBD treatments, Prof.
Shaji Sebastian, Dr. Vishal Sharma, Dr. Anuraag Jena and Tina Aswani-Omprakash co-authored this important article along with Dr. Mythili Menon Pathiyil and Dr. Arvind Kumar Venkatarama Raju. The systematic review makes a powerful call to action to include historically underrepresented communities in future IBD trials.